Husni Ahmed Abdullah Al-Goshae
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Husni Ahmed Abdullah Al-Goshae has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Xian Qiong
Department of Pain, Affiliated Hospital of North Sichuan Medical College
3 shared publications- Xiaoxue Xu
Department of Pain, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China
3 shared publications Hanfeng Yang
Department of Pain, Affiliated Hospital of North Sichuan Medical College
2 shared publicationsHongying Yang
Department of Pain, Affiliated Hospital of North Sichuan Medical College
2 shared publicationsMaojiang Yang
Department of Pain, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, 637000, People’s Republic of China
2 shared publicationsQiong Xian
Department of Pain, Affiliated Hospital of North Sichuan Medical College, Nanchong City, China
2 shared publications
Latest Publications
- Open Access
- 1 April 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13
CT-guided transforaminal versus C-arm-guided intradiscal ozone injection for cervical disc herniation: a comparative cohort study
Objective: This study compares a novel, disc-preserving minimally invasive technique targeting intraforaminal inflammation—CT-guided transforaminal ozone injection (Group A)—with the conventional intradiscal decompression approach using C-arm-guided injection (Group B) for the treatment of cervical disc herniation (CDH). Methods: A retrospective cohort study was conducted on 398 patients with CDH treated between January 2020 and June 2024. Patients were divided into two groups based on the treatment received: Group A ( n = 200), who received CT-guided transforaminal injections targeting the inflamed nerve root, and Group B ( n = 198), who received C-arm-guided intradiscal injections. Primary outcomes included the Visual Analogue Scale (VAS) for pain, the Neck Disability Index (NDI) for function, and overall efficacy assessed by the modified MacNab criteria. Secondary outcomes included procedural parameters and complication rates. Assessments were performed preoperatively and at 1 week, 1 month, 3 months, and 6 months post-procedure. Results: Both groups showed significant postoperative improvements in VAS and NDI scores ( p < 0.05). However, from 1 month onward, Group A demonstrated significantly lower (better) VAS and NDI scores compared to Group B ( p < 0.05). At the 6-month follow-up, the rate of “excellent” or “good” outcomes per MacNab criteria was significantly higher in Group A (93.0%) than in Group B (86.4%) ( p = 0.026). Group A had a longer mean procedure time but significantly less radiation exposure ( p < 0.001). Critically, no major complications, particularly discitis, occurred in Group A. In contrast, Group B had two cases (1.0%) of suspected discitis and a significantly higher rate of transient symptom exacerbation ( p = 0.014). Conclusion: CT-guided transforaminal ozone injection, a technique predicated on targeting intraforaminal inflammation rather than conventional intradiscal decompression, is associated with better 6-month outcomes for CDH. It provides more effective pain relief and functional improvement while demonstrating an enhanced safety profile by preserving disc integrity and eliminating the risk of iatrogenic discitis. These findings establish this approach as a precise, safe, and highly promising minimally invasive treatment strategy for cervical radiculopathy.
- 1 April 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13
Open AccessCT-guided transforaminal versus C-arm-guided intradiscal ozone injection for cervical disc herniation: a comparative cohort study
Objective: This study compares a novel, disc-preserving minimally invasive technique targeting intraforaminal inflammation—CT-guided transforaminal ozone injection (Group A)—with the conventional intradiscal decompression approach using C-arm-guided injection (Group B) for the treatment of cervical disc herniation (CDH). Methods: A retrospective cohort study was conducted on 398 patients with CDH treated between January 2020 and June 2024. Patients were divided into two groups based on the treatment received: Group A ( n = 200), who received CT-guided transforaminal injections targeting the inflamed nerve root, and Group B ( n = 198), who received C-arm-guided intradiscal injections. Primary outcomes included the Visual Analogue Scale (VAS) for pain, the Neck Disability Index (NDI) for function, and overall efficacy assessed by the modified MacNab criteria. Secondary outcomes included procedural parameters and complication rates. Assessments were performed preoperatively and at 1 week, 1 month, 3 months, and 6 months post-procedure. Results: Both groups showed significant postoperative improvements in VAS and NDI scores ( p < 0.05). However, from 1 month onward, Group A demonstrated significantly lower (better) VAS and NDI scores compared to Group B ( p < 0.05). At the 6-month follow-up, the rate of “excellent” or “good” outcomes per MacNab criteria was significantly higher in Group A (93.0%) than in Group B (86.4%) ( p = 0.026). Group A had a longer mean procedure time but significantly less radiation exposure ( p < 0.001). Critically, no major complications, particularly discitis, occurred in Group A. In contrast, Group B had two cases (1.0%) of suspected discitis and a significantly higher rate of transient symptom exacerbation ( p = 0.014). Conclusion: CT-guided transforaminal ozone injection, a technique predicated on targeting intraforaminal inflammation rather than conventional intradiscal decompression, is associated with better 6-month outcomes for CDH. It provides more effective pain relief and functional improvement while demonstrating an enhanced safety profile by preserving disc integrity and eliminating the risk of iatrogenic discitis. These findings establish this approach as a precise, safe, and highly promising minimally invasive treatment strategy for cervical radiculopathy.
- Open Access
- 1 March 2026
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 19, 1-10
Predictive Value of Epidural Gas Spread Pattern Following Transforaminal Ozone Injection for Clinical Outcomes in Cervical Radiculopathy: A Prospective Cohort Study
Background: Percutaneous interventions for cervical radiculopathy (CR) show variable efficacy, lacking reliable prognostic predictors. We hypothesized that epidural gas spread patterns during CT-guided ozone injection—using ozone as a native contrast agent—can functionally assess epidural adhesions and predict clinical outcomes. Methods: This prospective, observational cohort study enrolled 185 patients with single-segment CR completing a 6-month follow-up. During CT-guided transforaminal ozone injection, epidural gas spread was evaluated before administering the therapeutic dose. Patients were classified into Good Spread (GS; n=98) or Poor Spread (PS; n=87) groups. Primary (Neck Disability Index, NDI) and secondary (Visual Analog Scale, VAS) outcomes were assessed at baseline and multiple post-intervention time points up to 6 months. Results: Both groups showed significant NDI and VAS improvements from baseline (p< 0.001). However, the GS group exhibited significantly greater improvement at all follow-ups (p< 0.01). At 6 months, treatment success (≥ 50% NDI reduction) was 89.8% in the GS group versus 44.8% in the PS group (p< 0.001). Multivariate analysis identified a good spread pattern (OR=9.80, 95% CI: 4.51– 21.30; p< 0.001) and shorter symptom duration (OR=4.50, p=0.004) as independent predictors of treatment success. Conclusion: This study suggests that the epidural diffusion pattern of ozone gas during CT-guided transforaminal injection may be a useful predictor for clinical outcomes in CR. These findings highlight the potential role of epidural adhesions in treatment response. However, due to the single-center observational design, our findings may lack broad generalizability, and future randomized controlled trials are necessary to confirm these results.
- 1 March 2026
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 19, 1-10
Open AccessPredictive Value of Epidural Gas Spread Pattern Following Transforaminal Ozone Injection for Clinical Outcomes in Cervical Radiculopathy: A Prospective Cohort Study
Background: Percutaneous interventions for cervical radiculopathy (CR) show variable efficacy, lacking reliable prognostic predictors. We hypothesized that epidural gas spread patterns during CT-guided ozone injection—using ozone as a native contrast agent—can functionally assess epidural adhesions and predict clinical outcomes. Methods: This prospective, observational cohort study enrolled 185 patients with single-segment CR completing a 6-month follow-up. During CT-guided transforaminal ozone injection, epidural gas spread was evaluated before administering the therapeutic dose. Patients were classified into Good Spread (GS; n=98) or Poor Spread (PS; n=87) groups. Primary (Neck Disability Index, NDI) and secondary (Visual Analog Scale, VAS) outcomes were assessed at baseline and multiple post-intervention time points up to 6 months. Results: Both groups showed significant NDI and VAS improvements from baseline (p< 0.001). However, the GS group exhibited significantly greater improvement at all follow-ups (p< 0.01). At 6 months, treatment success (≥ 50% NDI reduction) was 89.8% in the GS group versus 44.8% in the PS group (p< 0.001). Multivariate analysis identified a good spread pattern (OR=9.80, 95% CI: 4.51– 21.30; p< 0.001) and shorter symptom duration (OR=4.50, p=0.004) as independent predictors of treatment success. Conclusion: This study suggests that the epidural diffusion pattern of ozone gas during CT-guided transforaminal injection may be a useful predictor for clinical outcomes in CR. These findings highlight the potential role of epidural adhesions in treatment response. However, due to the single-center observational design, our findings may lack broad generalizability, and future randomized controlled trials are necessary to confirm these results.
- Open Access
- 10 February 2026
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 27 (1)
Pain catastrophizing and postoperative satisfaction in cervical disc herniation: a 6-month prospective cohort study
Despite remarkable technical advancements in cervical minimally invasive interventional therapy, postoperative satisfaction remains suboptimal in a subset
- 10 February 2026
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 27 (1)
Open AccessPain catastrophizing and postoperative satisfaction in cervical disc herniation: a 6-month prospective cohort study
Despite remarkable technical advancements in cervical minimally invasive interventional therapy, postoperative satisfaction remains suboptimal in a subset
- 15 November 2025
- Published by Wonford Press Limited in Journal of Disease and Public Health
- Vol. 1 (2) , 64
Efficacy and Safety of CT-guided Ozone Neurolysis of the Gasserian Ganglion for Idiopathic Trigeminal Neuralgia in Elderly Patients (≥70 Years Old) - A Retrospective Observational Cohort Study
Objective: To retrospectively analyze the long-term efficacy, safety, and durability of CT-guided ozone neurolysis of the Gasserian Ganglion in elderly patients (≥70 years old) with Idiopathic Trigeminal Neuralgia (ITN). Methods: This was a retrospective, single-center, observational cohort study. Consecutive elderly patients with ITN meeting the inclusion criteria between January 2020 and December 2022 were enrolled. All patients underwent percutaneous puncture of the foramen ovale under CT guidance, followed by injection of 5 mL of a medical-grade ozone-oxygen mixture (concentration: 30 µg/mL) around the Gasserian Ganglion. The primary efficacy endpoint was the change in pain intensity assessed using the Visual Analog Scale (VAS). Secondary endpoints included the Barrow Neurological Institute (BNI) pain intensity score, pain recurrence rate, and patient satisfaction. All perioperative and postoperative complications were systematically recorded. All patients completed a 24-month follow-up period. Results: A total of 85 patients (mean age 76.5±4.2 years) were included. The mean VAS score significantly decreased from 8.2±0.9 at baseline to 2.1±1.5 at 24 months (P<0.001). At the final 24-month follow-up, 69 patients (81.2%) achieved satisfactory pain control (BNI grades I-III), among whom 55 patients (64.7%) were completely pain-free without medication (BNI grade I). Kaplan-Meier survival analysis estimated the recurrence-free survival rates at 12 and 24 months postoperatively to be 85.3% and 78.5%, respectively. The most common complication was transient facial hypesthesia (10 cases, 11.8%), which resolved spontaneously within 24 hours in all instances. No instances of anesthesia dolorosa, keratitis, intracranial hemorrhage, or other serious, permanent complications occurred. Conclusion: CT-guided ozone neurolysis of the Gasserian Ganglion is a safe, effective, and durable minimally invasive method for treating elderly patients with ITN. Its non-neurodestructive nature, excellent safety profile, and repeatability offer a highly valuable therapeutic option for this special patient population, who often have multiple comorbidities and are poor candidates for traditional craniotomy or neuroablative procedures.
- 15 November 2025
- Published by Wonford Press Limited in Journal of Disease and Public Health
- Vol. 1 (2) , 64
Efficacy and Safety of CT-guided Ozone Neurolysis of the Gasserian Ganglion for Idiopathic Trigeminal Neuralgia in Elderly Patients (≥70 Years Old) - A Retrospective Observational Cohort Study
Objective: To retrospectively analyze the long-term efficacy, safety, and durability of CT-guided ozone neurolysis of the Gasserian Ganglion in elderly patients (≥70 years old) with Idiopathic Trigeminal Neuralgia (ITN). Methods: This was a retrospective, single-center, observational cohort study. Consecutive elderly patients with ITN meeting the inclusion criteria between January 2020 and December 2022 were enrolled. All patients underwent percutaneous puncture of the foramen ovale under CT guidance, followed by injection of 5 mL of a medical-grade ozone-oxygen mixture (concentration: 30 µg/mL) around the Gasserian Ganglion. The primary efficacy endpoint was the change in pain intensity assessed using the Visual Analog Scale (VAS). Secondary endpoints included the Barrow Neurological Institute (BNI) pain intensity score, pain recurrence rate, and patient satisfaction. All perioperative and postoperative complications were systematically recorded. All patients completed a 24-month follow-up period. Results: A total of 85 patients (mean age 76.5±4.2 years) were included. The mean VAS score significantly decreased from 8.2±0.9 at baseline to 2.1±1.5 at 24 months (P<0.001). At the final 24-month follow-up, 69 patients (81.2%) achieved satisfactory pain control (BNI grades I-III), among whom 55 patients (64.7%) were completely pain-free without medication (BNI grade I). Kaplan-Meier survival analysis estimated the recurrence-free survival rates at 12 and 24 months postoperatively to be 85.3% and 78.5%, respectively. The most common complication was transient facial hypesthesia (10 cases, 11.8%), which resolved spontaneously within 24 hours in all instances. No instances of anesthesia dolorosa, keratitis, intracranial hemorrhage, or other serious, permanent complications occurred. Conclusion: CT-guided ozone neurolysis of the Gasserian Ganglion is a safe, effective, and durable minimally invasive method for treating elderly patients with ITN. Its non-neurodestructive nature, excellent safety profile, and repeatability offer a highly valuable therapeutic option for this special patient population, who often have multiple comorbidities and are poor candidates for traditional craniotomy or neuroablative procedures.
- Open Access
- 10 November 2025
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 16, 1662677
Hope for 17 patients with chronic cluster headache: efficacy evaluation of upper cervical spinal nerve root release surgery (2020–2023)
Objective: We aimed to evaluate the effectiveness and safety of upper cervical spinal nerve root release surgery in the treatment of chronic cluster headache. Method: This retrospective study reviewed 17 patients diagnosed with chronic cluster headache who underwent upper cervical spinal nerve root release surgery between August 2020 and March 2023. Data collected included demographic information, headache characteristics (frequency, duration, and intensity), preoperative treatment regimens, and postoperative outcomes. The surgical procedure aimed to alleviate nerve compression in the upper cervical region to improve neurological function. Patients were routinely followed postoperatively to assess the therapeutic impact through headache symptom relief assessments, including headache impact tests, pain scores, and quality of life evaluations. Result: All 17 patients completed the surgery without severe complications. Our 6-month follow-up data demonstrated notable improvements in headache symptoms, with a significant reduction in the frequency and duration of headache episodes and alleviation of pain intensity. Specifically, the Visual Analog Scale (VAS) scores at 1 week, 1 month, 3 months, and 6 months post-surgery were (2.76 ± 1.16), (2.25 ± 0.45), (1.95 ± 0.47), and (1.75 ± 0.48), respectively. The frequency of headache episodes decreased to (1.96 ± 0.42), (1.45 ± 0.36), (0.95 ± 0.32), and (0.76 ± 0.28) times per month, respectively. The duration of each episode was reduced to (14.68 ± 4.75), (9.44 ± 3.28), (6.65 ± 2.52), and (4.55 ± 1.34) minutes, respectively. Moreover, patients reported significant enhancements in quality of life and resumed normal work and social activities. Conclusion: The findings from this case series suggest that upper cervical spinal nerve root release surgery is a safe and effective treatment for chronic cluster headache, offering substantial clinical improvements. However, due to the small sample size, further large-scale, placebo-controlled studies are essential to corroborate these results, validate the long-term efficacy and safety of the procedure, and accurately determine the contribution of the surgical intervention beyond the placebo effect.
- 10 November 2025
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 16, 1662677
Open AccessHope for 17 patients with chronic cluster headache: efficacy evaluation of upper cervical spinal nerve root release surgery (2020–2023)
Objective: We aimed to evaluate the effectiveness and safety of upper cervical spinal nerve root release surgery in the treatment of chronic cluster headache. Method: This retrospective study reviewed 17 patients diagnosed with chronic cluster headache who underwent upper cervical spinal nerve root release surgery between August 2020 and March 2023. Data collected included demographic information, headache characteristics (frequency, duration, and intensity), preoperative treatment regimens, and postoperative outcomes. The surgical procedure aimed to alleviate nerve compression in the upper cervical region to improve neurological function. Patients were routinely followed postoperatively to assess the therapeutic impact through headache symptom relief assessments, including headache impact tests, pain scores, and quality of life evaluations. Result: All 17 patients completed the surgery without severe complications. Our 6-month follow-up data demonstrated notable improvements in headache symptoms, with a significant reduction in the frequency and duration of headache episodes and alleviation of pain intensity. Specifically, the Visual Analog Scale (VAS) scores at 1 week, 1 month, 3 months, and 6 months post-surgery were (2.76 ± 1.16), (2.25 ± 0.45), (1.95 ± 0.47), and (1.75 ± 0.48), respectively. The frequency of headache episodes decreased to (1.96 ± 0.42), (1.45 ± 0.36), (0.95 ± 0.32), and (0.76 ± 0.28) times per month, respectively. The duration of each episode was reduced to (14.68 ± 4.75), (9.44 ± 3.28), (6.65 ± 2.52), and (4.55 ± 1.34) minutes, respectively. Moreover, patients reported significant enhancements in quality of life and resumed normal work and social activities. Conclusion: The findings from this case series suggest that upper cervical spinal nerve root release surgery is a safe and effective treatment for chronic cluster headache, offering substantial clinical improvements. However, due to the small sample size, further large-scale, placebo-controlled studies are essential to corroborate these results, validate the long-term efficacy and safety of the procedure, and accurately determine the contribution of the surgical intervention beyond the placebo effect.
- 15 October 2025
- Published by PHARMAKON-PRESS in Epitheorese Klinikes Farmakologias kai Farmakokinetikes – Greek Edition
- Vol. 43 (Sup1) , 79-82
Optimizing wound healing in diabetic foot ulcers: impact of ulcer location and treatment approaches
Background: Diabetic foot ulcers (DFUs) are a common and severe complication of diabetes mellitus, often leading to prolonged healing times and increased risk of amputation. Aim: This study evaluates the healing period among diabetic cases with ulcers affecting different anatomical areas and assesses the impact of honey and hydrogel treatments on wound closure time. Methodology: A prospective, single-blinded, randomized controlled trial was conducted at the Diabetic Foot Center, King Fahad Specialist Hospital, Saudi Arabia, from February 2019 to February 2023. The study included 120 participants with type 2 diabetes and second-degree foot ulcers. Participants were divided into four treatment groups: honey alone, hydrogel alone, honey and hydrogel combination, and a control group receiving Fucidin ointment. Healing times were analyzed based on ulcer location and treatment type. Results: The mean healing time across all groups was 12.76±4.08 days. Healing times varied significantly based on the ulcer location (p=0.002), with hindfoot wounds taking the longest to heal. Among treatment groups, the combination of honey and hydrogel demonstrated the shortest healing time (10.83 ± 3.5 days), which was significantly faster than the control group (p=0.004). This combination was particularly effective in ulcers on the forefoot. Additionally, greater wound size correlated with longer healing times (p<0.001). Conclusion: Wound location significantly affects healing duration in diabetic ulcers. The combination of honey and hydrogel enhances wound closure rates, especially in ulcers affecting the forefoot. These findings support the incorporation of honey-hydrogel therapy in clinical management of DFUs.
- 15 October 2025
- Published by PHARMAKON-PRESS in Epitheorese Klinikes Farmakologias kai Farmakokinetikes – Greek Edition
- Vol. 43 (Sup1) , 79-82
Optimizing wound healing in diabetic foot ulcers: impact of ulcer location and treatment approaches
Background: Diabetic foot ulcers (DFUs) are a common and severe complication of diabetes mellitus, often leading to prolonged healing times and increased risk of amputation. Aim: This study evaluates the healing period among diabetic cases with ulcers affecting different anatomical areas and assesses the impact of honey and hydrogel treatments on wound closure time. Methodology: A prospective, single-blinded, randomized controlled trial was conducted at the Diabetic Foot Center, King Fahad Specialist Hospital, Saudi Arabia, from February 2019 to February 2023. The study included 120 participants with type 2 diabetes and second-degree foot ulcers. Participants were divided into four treatment groups: honey alone, hydrogel alone, honey and hydrogel combination, and a control group receiving Fucidin ointment. Healing times were analyzed based on ulcer location and treatment type. Results: The mean healing time across all groups was 12.76±4.08 days. Healing times varied significantly based on the ulcer location (p=0.002), with hindfoot wounds taking the longest to heal. Among treatment groups, the combination of honey and hydrogel demonstrated the shortest healing time (10.83 ± 3.5 days), which was significantly faster than the control group (p=0.004). This combination was particularly effective in ulcers on the forefoot. Additionally, greater wound size correlated with longer healing times (p<0.001). Conclusion: Wound location significantly affects healing duration in diabetic ulcers. The combination of honey and hydrogel enhances wound closure rates, especially in ulcers affecting the forefoot. These findings support the incorporation of honey-hydrogel therapy in clinical management of DFUs.
- Open Access
- 13 February 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (4) , 1239
Evaluating the Role of Vitamin D in Prediabetes Management, Insights from RCTs in the MENA Region: A Comprehensive Systematic Review
Background/Objectives: The association between vitamin D deficiency and prediabetes has been extensively investigated, yet the findings remain inconsistent, with limited data available on the MENA region. This systematic review aims to assess the relationship between vitamin D deficiency and prediabetes in the Middle East and North Africa (MENA) region, focusing specifically on randomized controlled trials (RCTs). Methods: A comprehensive literature search was performed across four databases, which were Ovid MEDLINE, Cochrane, Scopus, and PubMed. RCTs studies conducted on people with prediabetes aged 15 years and older who live in the MENA region, and receiving vitamin D supplementation were included in the study. Results: From 2194 studies identified from the literature search, only 51 studies were considered eligible for full-text review. Ultimately, seven articles were finalized for inclusion. The findings from these studies showed mixed results, where some studies indicated that vitamin D supplementation had no significant effect on these outcomes. The remaining reported improvements in insulin sensitivity and a reduced risk of progression to type 2 diabetes with vitamin D supplementation. Conclusions: This systematic review examines the complex and contradictory relationship between vitamin D deficiency and prediabetes in the MENA region. Due to the mixed pattern seen in the intervention of vitamin D to prevent the development of type 2 diabetes, further research is necessary to elucidate the underlying mechanisms and potential confounding factors specifically in population of the MENA region.
- 13 February 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (4) , 1239
Open AccessEvaluating the Role of Vitamin D in Prediabetes Management, Insights from RCTs in the MENA Region: A Comprehensive Systematic Review
Background/Objectives: The association between vitamin D deficiency and prediabetes has been extensively investigated, yet the findings remain inconsistent, with limited data available on the MENA region. This systematic review aims to assess the relationship between vitamin D deficiency and prediabetes in the Middle East and North Africa (MENA) region, focusing specifically on randomized controlled trials (RCTs). Methods: A comprehensive literature search was performed across four databases, which were Ovid MEDLINE, Cochrane, Scopus, and PubMed. RCTs studies conducted on people with prediabetes aged 15 years and older who live in the MENA region, and receiving vitamin D supplementation were included in the study. Results: From 2194 studies identified from the literature search, only 51 studies were considered eligible for full-text review. Ultimately, seven articles were finalized for inclusion. The findings from these studies showed mixed results, where some studies indicated that vitamin D supplementation had no significant effect on these outcomes. The remaining reported improvements in insulin sensitivity and a reduced risk of progression to type 2 diabetes with vitamin D supplementation. Conclusions: This systematic review examines the complex and contradictory relationship between vitamin D deficiency and prediabetes in the MENA region. Due to the mixed pattern seen in the intervention of vitamin D to prevent the development of type 2 diabetes, further research is necessary to elucidate the underlying mechanisms and potential confounding factors specifically in population of the MENA region.